11th Annual MassBio Investors Forum

Tuesday, October 6 2009

MassBio Investors Forum
Executing the Biotech Business Model: A New Direction for Biotech
October 6, 2009
Sheraton Boston Hotel

 

Find Partnerships. Raise Capital.

Register Now!

Join your colleagues from:

  • Anglo Irish Bank, Essex Woodlands Healthcare Ventures, Exponential Pharma Ventures LLC, Flagship Ventures, GE Healthcare Financial Services, IncTANK Ventures, The Life Science Group, Liberty Tree Advisors, LLC, Lumira Captial, Mass Medical Angels, MP Healthcare Venture Management, Inc., MPM Capital LP, NeoMed Management, Partners Innovation Fund, Polaris Venture Partners, Prism VentureWorks, PureTech Ventures, Silicon Valley Bank, Third Rock Ventures, TVM Capital and other venture funds and investors
  • EMD Serono, Genzyme Ventures, GlaxoSmithKline, Johnson & Johnson, Lilly Ventures, MedImmune Ventures, Merck & Co., Inc., Novartis Venture Funds, Pfizer, Inc., Sanofi-Aventis and other BD executives from big pharma
  • Accelerated Cure Project, American Cancer Society, Averion International, Avila Therapeutics, Celator Pharmaceuticals, Inc. Center for Drug Discovery, Northeastern University, Concert Pharmaceuticals, Inc., EnVivo Pharmaceuticals, Eutropics Pharmaceuticals, Galena, Harvard Medical School, Hepregen Corporation, Juvenile Diabetes Research Foundation, Massachusetts General Hospital, Mersana Therapeutics, MicroCHIPS, Inc., Microtest Laboratories Inc., Microtest Laboratories, Inc., Nycomed, PCI Synthesis, Percivia LLC, PX-Therapeutics, RainDance Technologies Inc., Sepracor Inc., Tolerx, Inc., TransForm Pharmaceuticals, Inc., TransMolecular, Inc., and many more from biotech, disease foundations and other areas of industry

Please join us for the 2009 MassBio Investors Forum on October 6th at the Sheraton Copley Hotel in Boston. This is THE pre-eminent event in Boston to build R&D partnerships and drive investment from non-dilutive and traditional financing sources.

The day is organized into three concurrent tracks, open to all delegates:

  • Company presentation program - slots are available, apply to present now.
  • Partnering meetings arranged in advance using PartneringOne meeting software (view tutorial)
  • Keynote and panel presentations designed to provide real-world advice on partnering and financing strategies

Registration Fees:

Individual Registration Type Until Sept. 1, 2009 Until Oct. 5, 2009 On-Site Registration
MassBio Member $550.00 $650.00 $700.00
Non-member $799.00 $899.00 $949.00
MassBio Member
  • Academic
  • Non-profit
  • Government
$300.00 $300.00 $350.00
Non-member
  • Academic
  • Non-profit
  • Government
$350.00 $350.00 $400.00
  • Investment Banker
  • Venture Capitalist - registered with NVCA and/or NEVCA
Free Free Free
MassBio Member Disease Foundation Free Free Free
Non-member Disease Foundation $99.00 $99.00 $99.00
Credentialed members of the press are welcome to attend free of charge provided they obtain permission from:
Sarah MacDonald
Director of Communications
MassBio
617-674-5115
sarah.macdonald@massbio.org

 

Sponsorship Opportunities
In addition to Forum panel sponsorships, numerous other highly visible sponsorship opportunities exist.

All Sponsorships Include:

  • Complimentary conference registrations
  • Pre-event advertising
  • MBC website recognition
  • Program guide acknowledgment
  • On-site signage & acknowledgment

Secure your sponsorship now!

For additional information, contact Lauren Laidlaw at lauren.laidlaw@massbio.org or 617-674-5100.

MassBio wishes to thank our sponsors:

Fisher Scientific Indigo Insurance Services
EBD Group Goodwin Procter
Merck Canada
American Cancer Society MassDevelopment
Bingham McCutchen Deloitte

Semprus

 

 ACS

 

MOITI

Massachusetts Life Sciences Center

Sturgeon Liberty

Share MassBio

 

EvaluatePharma

MassBio